Science and the Pope

In a recent editorial, Richard Gallagher and Ivan Oransky conclude with the suggestion that "officials keep the human person of Pope John Paul II in view when crafting their next document.

Written byD. Joy Riley
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

In a recent editorial, Richard Gallagher and Ivan Oransky conclude with the suggestion that "officials keep the human person of Pope John Paul II in view when crafting their next document. After all, Parkinson disease, which afflicted the late Pope, is one of the conditions for which stem cell research seems the most promising."1

To a large extent, this last point is true, but perhaps not in the way Gallagher and Oransky believe. Pope John Paul II, the recently deceased leader of the Catholic Church, was a strong supporter of human rights, and the respect due human life – at all stages of life. He would have been the first to refuse the destruction of human embryos to harvest stem cells in order to treat his condition. It would be a sound idea for the crafters of the next Catholic Church document regarding scientific research to keep this in mind.

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies